Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

CMPI - Checkmate Pharmaceuticals Inc

Close
10.5
0.020   0.190%

Share volume: 0
Last Updated: Fri 27 May 2022 10:00:00 PM CEST

PREVIOUS CLOSE
CHG
CHG%
$10.48
0.02
0.19%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Historical prices Events Documents Notes Dividends
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$10.50
P/E Ratio 
0.00
DAY RANGE
$10.50 - $10.50
EPS 
$0.00
52 WEEK RANGE
$0.00 - $0.00
52 WEEK CHANGE
$0.00
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
22.038 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$0
AVERAGE 30 VOLUME 
$0
Company detail
CEO:
Region: US
Website: checkmatepharma.com
Employees: 25
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry:
Sector:

Checkmate Pharmaceuticals, Inc. operates as a biotechnology company. The Company discovers and develops novel approaches for cancer immunotherapy such as immuno-oncology. Checkmate Pharmaceuticals serves patients worldwide.

Recent news